Form 4 holding
Director
X4 Pharmaceuticals, Inc
- Security class
- Common Stock
- Shares / value
- 4,722
- Estimated value
- $897
- Report date
- 09 Jun 2025
- Price
- $0.1900
- Ownership
- Direct
Gary Bridger
Insider Reports History
- Location
- Vancouver, British Columbia, Canada
- Signature
- /s/ David Kirske, attorney-in-fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Gary Bridger:
Form 4 holding
Director
X4 Pharmaceuticals, Inc
- Security class
- Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 01 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Gary Bridger
4
XFOR
X4 Pharmaceuticals, Inc
- Report period
- 01 Jan 2026
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 07 Jan 2026, 16:00
- Role
- Director
- Next action
- Open filing details
4
XFOR
X4 Pharmaceuticals, Inc
- Report period
- 09 Jun 2025
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 10 Jun 2025, 16:30
- Role
- Director
- Next action
- Open filing details
4
XFOR
X4 Pharmaceuticals, Inc
- Report period
- 10 Jun 2024
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 11 Jun 2024, 16:12
- Role
- Director
- Next action
- Open filing details
4
XFOR
X4 Pharmaceuticals, Inc
- Report period
- 13 Jun 2023
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 14 Jun 2023, 17:05
- Role
- Director
- Next action
- Open filing details
4
XFOR
X4 Pharmaceuticals, Inc
- Report period
- 06 Jun 2022
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 27 Jun 2022, 16:17
- Role
- Director
- Next action
- Open filing details
4
XFOR
X4 Pharmaceuticals, Inc
- Report period
- 02 Jun 2021
- Transactions
- 1
- Transaction value
- +$57,000
- Filing time
- 02 Jun 2021, 17:04
- Role
- Director
- Next action
- Open filing details